These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18769114)

  • 1. Potential for all-trans retinoic acid (tretinoin) to enhance interferon-alpha treatment response in chronic myelogenous leukemia, melanoma, myeloma and renal cell carcinoma.
    Kast RE
    Cancer Biol Ther; 2008 Oct; 7(10):1515-9. PubMed ID: 18769114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia.
    Sacchi S; Kantarjian HM; Freireich EJ; O'Brien S; Cortes J; Rios MB; Kornblau S; Giles FJ; Koller C; Gajewski J; Talpaz M
    Leuk Lymphoma; 1999 Nov; 35(5-6):483-9. PubMed ID: 10609785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of all-trans retinoic acid in the accelerated phase or early blastic phase of chronic myeloid leukemia: a study of the Eastern Cooperative Oncology Group (E1993).
    Dutcher JP; Lee S; Gallagher RE; Makary AZ; Hines JD; Londer H; Farnen JP; Bennett JM; Paietta E; Rowe JM; Goloubeva O; Wiernik PH;
    Leuk Lymphoma; 2005 Mar; 46(3):377-85. PubMed ID: 15621827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot study of combined therapy with interferon-alpha, arabinosyl cytosine and all-trans retinoic acid in patients with chronic myeloid leukemia in the chronic phase.
    Russo D; Marin L; Bertone A; Tiribelli M; Testoni N; Martinelli G
    Haematologica; 1999 Feb; 84(2):185-7. PubMed ID: 10091422
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase 1/2 clinical trial of interferon alpha2b and weekly liposome-encapsulated all-trans retinoic acid in patients with advanced renal cell carcinoma.
    Boorjian SA; Milowsky MI; Kaplan J; Albert M; Cobham MV; Coll DM; Mongan NP; Shelton G; Petrylak D; Gudas LJ; Nanus DM
    J Immunother; 2007 Sep; 30(6):655-62. PubMed ID: 17667529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of interferon-alpha and all-trans retinoic acid in metastatic renal cell carcinoma.
    Escudier B; Ravaud A; Berton D; Chevreau C; Douillard JY; Dietrich PY
    J Immunother; 1998 Jan; 21(1):62-4. PubMed ID: 9456438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ATRA (all-trans retinoic acid) in chronic myeloid leukemia?].
    Rák K
    Orv Hetil; 2002 Jun; 143(23):1449-50; author reply 1450. PubMed ID: 12132331
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of retinoic acid treatment on cytogenetic remission of chronic myeloid leukaemia.
    Egyed M; Kollár B; Rumi G; Keller E; Vass J; Fekete S
    Acta Haematol; 2003; 109(2):84-9. PubMed ID: 12624492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of retinoic acid on the cytogenetic remission in the first chronic phase of chronic myeloid leukemia treated with interferon].
    Egyed M; Mihályfalvi Z; Kollár B; Rumi G; Keller E; Vass J; Fekete S
    Orv Hetil; 2001 Nov; 142(44):2421-5. PubMed ID: 11766235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological activity of all-trans-retinoic acid with and without tamoxifen and alpha-interferon 2a in breast cancer patients.
    Toma S; Raffo P; Nicolo G; Canavese G; Margallo E; Vecchio C; Dastoli G; Iacona I; Regazzi-Bonora M
    Int J Oncol; 2000 Nov; 17(5):991-1000. PubMed ID: 11029503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-trans retinoic acid combined with interferon-alpha effectively inhibits granulocyte-macrophage colony formation in chronic myeloid leukemia.
    Zheng A; Savolainen ER; Koistinen P
    Leuk Res; 1996 Mar; 20(3):243-8. PubMed ID: 8637219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of interferon alpha with either Ara-C or ATRA in vitro reduces the selective action of interferon against CML CFU-GM.
    Marley SB; Davidson RJ; Goldman JM; Gordon MY
    Leukemia; 2000 Aug; 14(8):1396-400. PubMed ID: 10942234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATRA promotes alpha tocopherol succinate-induced apoptosis in freshly isolated leukemic cells from chronic myeloid leukemic patients.
    Kumar S; Khanduja KL; Verma N; Verma SC; Avti PK; Pathak CM
    Mol Cell Biochem; 2008 Jan; 307(1-2):109-19. PubMed ID: 17874176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High, intermittent dose of all-trans retinoic acid in combination with alpha-interferon for advanced multiple myeloma.
    Juturi J; Bukowski RA; Bocock K; Bloom T; Finke J; Hussein MA
    Haematologica; 2001 Jul; 86(7):776-7. PubMed ID: 11454541
    [No Abstract]   [Full Text] [Related]  

  • 15. All-trans retinoic acid in combination with alpha-interferon and dexamethasone for advanced multiple myeloma.
    Musto P; Sajeva MR; Sanpaolo G; D'Arena G; Scalzulli PR; Carotenuto M
    Haematologica; 1997; 82(3):354-6. PubMed ID: 9234591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.
    Touma SE; Goldberg JS; Moench P; Guo X; Tickoo SK; Gudas LJ; Nanus DM
    Clin Cancer Res; 2005 May; 11(9):3558-66. PubMed ID: 15867260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class 1 HDAC and HDAC6 inhibition inversely regulates CD38 induction in myeloma cells via interferon-α and ATRA.
    Bat-Erdene A; Nakamura S; Oda A; Iwasa M; Teramachi J; Ashtar M; Harada T; Miki H; Tenshin H; Hiasa M; Fujii S; Sogabe K; Oura M; Udaka K; Kagawa K; Yoshida S; Aihara KI; Kurahashi K; Endo I; Abe M
    Br J Haematol; 2019 Jun; 185(5):969-974. PubMed ID: 30474853
    [No Abstract]   [Full Text] [Related]  

  • 18. [Modulation of adriamycin cytotoxicity on K 562 and K562adri cells by interferon alpha and/or all-trans-retinoic acid].
    Dufour P; Feugeas O; Bergerat JP; Oberling F
    Bull Cancer; 1994 Oct; 81(10):894-6. PubMed ID: 7734774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer immunotherapy: the interferon-alpha experience.
    Kirkwood J
    Semin Oncol; 2002 Jun; 29(3 Suppl 7):18-26. PubMed ID: 12068384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of multiple myeloma with all-trans retinoic acid alone and in combination with chemotherapy: a phase I/II trial.
    Koskela K; Pelliniemi TT; Pulkki K; Remes K
    Leuk Lymphoma; 2004 Apr; 45(4):749-54. PubMed ID: 15160951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.